FY09
Assets95.90
Net Worth30.51
Total Debt43.82
RevenueAnnualised basis43.82
EBITDAAnnualised basis21.76
PATAnnualised basis10.72
EBITDA Margin (%)49.66
At a glance
Updated 2026-09-27Astec LifeSciences is an IPO with an issue size of ₹61.50 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹61.50 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗PENDINGBidding has not started yet.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets98.17₹ Cr · +88.8% vs prior year
Net Worth33.95₹ Cr · +135.4% vs prior year
FY08
Assets77.21
Net Worth21.37
Total Debt32.94
RevenueAnnualised basis32.94
EBITDAAnnualised basis15.72
PATAnnualised basis7.93
EBITDA Margin (%)47.72
FY07
Assets52.01
Net Worth14.42
Total Debt23.07
RevenueAnnualised basis23.07
EBITDAAnnualised basis6.44
PATAnnualised basis3.62
EBITDA Margin (%)27.92
30-Jun-09
Assets98.17
Net Worth33.95
Total Debt40.32
RevenueAnnualised basis40.33
EBITDAAnnualised basis6.67
PATAnnualised basis3.43
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Astec LifeSciences IPO | — | 7.21 x | — | — |
| Prasol Chemicals IPO | — | 48.13 x | — | — |
| Kronox Lab IPO | — | 24.47 x | — | — |
| Archean Chemical IPO | — | 16.78 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-27.
IPO UPDATE ALERTS
Register for IPO Updates →Track Astec LifeSciences without missing an update
Register for subscription, GMP, allotment and listing notifications.